MEDP

Medpace Holdings

498.34

+8.86+1.81%

After Hours: 498.34 0.00 0.00%16:10 04/02 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE481.36/489.48

TODAY RANGE481.36-501.33

VOL284.41K

MARKET CAP14.14B

52 WEEK RANGE250.05-628.92

AVG VOL (3M)341.73K

% TURNOVER1.00%

TURNOVER--

P/E (TTM)32.62

% RANGE4.08%

EPS(TTM)15.28

P/E(FORWARD)29.10

P/B30.72

BVPS16.22

DIVIDEND--

P/S5.57

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP11.38B

SHARES OUTSTANDING28.38M

NEXT EARNINGS04/20-04/24

FREE FLOAT22.84M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

NASDAQ·1d ago
Medpace (MEDP) Beats Stock Market Upswing: What Investors Need to Know
Reuters·1d ago
Medpace announces annual shareholder meeting invitation and proxy statement filing
Reuters·1d ago
Medpace publishes 2025 annual report on Form 10-K filing
Reuters·3d ago
AI-led selloff in contract research firms may be misjudging disruption risk
TipRanks·6d ago
New Medpace-Backed PET Tracer Study Targets Precision Cancer Imaging
Simply Wall St·03/25 22:09
A Look At Medpace Holdings (MEDP) Valuation After Strong Recent Shareholder Returns
Reuters·03/25 06:28
Zelluna FY2025 annual report published; cash and cash equivalents climb to NOK 78 million
Reuters·03/24 20:05
Medpace to report first-quarter 2026 results and host earnings call
Dow Jones·03/24 20:05
Press Release: Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026
TipRanks·03/20 02:07
Top Medpace Executive Makes Major Move With High-Value Stock Sale
Reuters·03/17 07:48
Zelluna selects Medpace as CRO for ZIMA-101 Phase 1 trial
Reuters·03/16 21:24
Medpace Holdings Inc. Announces Annual Stockholders Meeting
Simply Wall St·03/15 09:24
Is Medpace Holdings (MEDP) Still Appealing After Recent Volatility And Zelluna Partnership Expectations
Simply Wall St·03/13 07:41
Does Barclays’ AI Reassessment Reframe Medpace (MEDP) as a Higher-Quality, More Durable Growth Story?
Simply Wall St·03/12 04:56
A Look At Medpace Holdings (MEDP) Valuation After Recent Share Price Pullback

Same Industry

Name/Symbol

Change%

Price

MEDP

Regeneron Pharmaceuticals

REGN

+0.60%

777.25

GridAI Tech

GRDX

+22.77%

2.480

BIONTECH

BNTX

-2.04%

85.68

United Therapeutics Corp.

UTHR

+13.02%

590.90

Vertex Pharmaceuticals Inc

VRTX

-4.56%

433.07

SIGA

Moderna

MRNA

-7.49%

49.56

Charles Riv Labs Intl Inc

CRL

-3.62%

159.16

TLPH

China Biologic

CBPO

0.00%

119.99

ICON PLC

ICLR

-0.97%

102.08

IQV

MOLECULAR PARTNERS AG

MOLN

-3.02%

3.930

Arcturus Therape

ARCT

+1.68%

7.85

PRA Health

PRAH

0.00%

165.21

Gilead Sciences Inc

GILD

+0.67%

140.30

INCY

APVO

Biospecifics

BSTC

0.00%

88.53

KNSA

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.